CASE DISCUSSION
Cancer Risks in Diabetic Patients: What to Know
Presented India by Dr. Priyasha DamodaraViews
14,853
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Diabetes, particularly Type 2, has been linked to an increased risk of certain cancers, including liver, pancreas, breast, and colon cancer. High blood sugar levels, insulin resistance, and chronic inflammation associated with diabetes can create a favorable environment for cancer cell growth....
Case Summary
- Diabetes is a chronic disease where the pancreas doesn't produce enough insulin or the body can't effectively use the insulin it produces. Type 1 diabetes involves lack of insulin production due to autoimmune destruction of pancreatic beta cells, while type 2 diabetes is characterized by insulin resistance and dysfunctional insulin secretion. Type 2 diabetes is more commonly associated with cancer risk and is influenced by obesity and lifestyle factors.
Speaker Profile
Dr. Priyasha Damodara
Medical Director, Oncoclarity, Co-founder Paxa Health, Bengaluru**Dr. Priyasha Damodara** is a distinguished Radiation Oncologist with extensive experience in cancer care, radiation therapy, and multidisciplinary oncology management. She has served as a Consultant Radiation Oncologist at Star Hospitals, Hyderabad, and holds leadership roles as Medical Director and Co-founder of Oncoclarity and Paxa Health. An alumna of Osmania Medical College, her areas of interest include advanced radiation treatment planning, personalized cancer therapy, and multidisciplinary oncology care. With a strong focus on evidence-based and patient-centered treatment, Dr. Damodara is also actively involved in healthcare innovation and improving access to quality cancer care.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.